Here’s How It Works
For the first time, Blueprint Diagnostics can accurately predict:
- Step 1: We test your genetics
- Step 2: We tell you what won’t work
- Step 3: We offer the drug that might work best
We use our advanced GigaAssay™ to look at all 5,886 known HER2+ mutations — not just a few. We measure how your specific genetics respond to each of the top drugs in real cells, not just in theory.
We’ll show you exactly which drugs won’t bind, won’t activate, and won’t help — so you can avoid wasted time, unnecessary side effects, and false hope.
If our biosimilar is a match, we’ll supply it directly to you or your provider. If not, we’ll let you know which drugs might be better — even if we don’t sell them.